États des lieux et expertise de l’usage hors AMM du méthotrexate en gynécologie–obstétrique : travail du CNGOF

Autor: Marret, H., Fauconnier, A., Dubernard, G., Misme, H., Lagarce, L., Lesavre, M., Fernandez, H., Mimoun, C., Tourette, C., Curinier, S., Rabishong, B., Agostini, A.

Publikováno v: In La Revue Sage-Femme June 2015 14(3):114-121

Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy

Autor: Martin , Jean-Charles, Dutour , M, Abdesselam , B, Ancel , M, Kober , B, Mrad , M., Darmon , M., Ronsin , M., Pradel , M., Lesavre , M, Martin , M., Jacquier , B., Lefur , B, Bernard , B, Gaborit , B., Dutour , A., Abdesselam , I., Ancel , P., Kober , F., Mrad , G., Darmon , P., Ronsin , O., Pradel , V., Lesavre , N., Jacquier , A., Lefur , Y., Bernard , M.

Publikováno v: Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism, Wiley, 2016, 18 (9), pp.882-891. 〈10.1111/dom.12680〉

International audience; To conduct a prospective randomized trial to investigate the effect of glucagon-like peptide-1 (GLP-1) analogues on ectopic fat stores.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8036f9ed370ce97ee477d85ffa0d37e9
https://hal.archives-ouvertes.fr/hal-01770003

Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français

Autor: Marret, Henri, Simon, E, Beucher, Gael, Dreyfus, Michel, Gaudineau, Adrien, Vayssière, Christophe, Lesavre, M, Pluchon, M, Winer, Norbert, Fernandez, H, Aubert, J, Bejan Angoulvant, T, Jonville-Bera, Annie-Pierre, Clouqueur, E, Houfflin-Debarge, V, Garrigue, A, Pierre, F, Collège national des gynécologues obstétriciens français, .

Publikováno v: European Journal of Obstetrics & Gynecology and Reproductive Biology
European Journal of Obstetrics & Gynecology and Reproductive Biology, Elsevier, 2015, 187, pp.80-4. ⟨10.1016/j.ejogrb.2015.01.018⟩

The literature suggests that misoprostol can be offered to patients for off-label use as it has reasonable efficacy, risk/benefit ratio, tolerance and patient satisfaction, according to the criteria for evidence-based medicine. Both the vaginal and s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9680ba5690e4c2b49c97a7a6663619
https://pubmed.ncbi.nlm.nih.gov/25701235

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.